Abstract. Extracellular nucleotides are primary signals for tissue injury, acting together with various chemical mediators such as prostanoids at the inflammatory site. We investigated whether prostaglandin E 2 (PGE 2 ) affects purinergic signaling in murine J774 macrophages. J774 cells expressed four different purinoceptor mRNAs: the ionotropic P2X 4 and P2X 7 receptors and G-protein-coupled P2Y 2 and P2Y 6 receptors. Functional responses mediated by these purinoceptor subtypes were confirmed by measurement of intracellular Ca ] i elevation. Stimulation of J774 cells by UDP or BzATP increased the production of macrophage inflammatory peptide-α (MIP-α). PGE 2 abolished the UDP-induced MIP-α production, but not the BzATP-induced one. These results demonstrate that purinergic signalings in macrophages were regulated by PGE 2 in a subtype-specific manner. The different inhibitory effects on distinct purinoceptor functions may be related to the antiinflammatory property of PGE 2 .
Introduction
Extracellular nucleotides are now recognized as important signaling molecules; act as neurotransmitters; and serve as modulators of autonomic function, vessel tone, and mechanosensory transduction (1 -3) . In addition to the regulation of physiological response, extracellular nucleotides play an important role for initiation and progression of acute inflammation because they are present at high concentration within the cytoplasm and released to the extracellular space following tissue damage (1, 2, 4) . The accumulation of adenine and uridine nucleotides in the pericellular space triggers activation of immune cells, including macrophages, monocytic cells, and lymphocytes via stimulation of P2-purinergic receptors (5 -8) . Currently, P2 purinergic receptors have been separated into two families; the P2X ligand-gated ion channels and P2Y G-proteincoupled receptors (3) . Seven subtypes of P2X receptors (P2X 1,2,3,4,5,6,7 ) and eight subtypes of P2Y receptors (P2Y 1,2,4,6,11,12,13,14 ) have been cloned and characterized (2) . Various P2-receptor subtypes have been demonstrated to mediate the nucleotide-induced early inflammatory responses. For example, extracellular ATP stimulates P2X 7 receptors in macrophages, leading to pro-inflammatory signaling pathways including caspase-1 activation, interleukin (IL)-1β release, and nitric oxide synthesis (5, 9, 10) . In monocytic cells, UDP activates G-protein-coupled P2Y 6 receptors to induce IL-8 release (11) . Therefore, the regulation of purinergic signaling in the immune cells is suggested to be a potential therapeutic target for the inflammatory disorders (2, 4) .
In addition to nucleotides, various chemical mediators are accumulated at sites of tissue damage. Prostaglandin E 2 (PGE 2 ), one of the most important chemical mediators, is generated from arachidonic acid via the cyclooxygenase pathway and rapidly increased at the inflammatory sites (12) . PGE 2 mediates various inflammatory responses, including generation of pyrogenic fever and hyperalgesia (12, 13) . On the other hand, there is increasing evidence that PGE 2 acts as anti-inflammatory mediator, especially in immune cells. Indeed, PGE 2 impairs inflammatory activation of macrophages by inhibiting the expression of tumor necrosis factor (TNF)-α, IL-12 (14, 15) , and various chemokines (16, 17) . It is therefore possible that the nucleotide signaling in inflammatory process is also modulated by PGE 2 .
However, the precise role of PGE 2 in purinergic signaling remains to be elucidated. In this study, we examined a possible cross talk between the purinergic and prostanoid signalings in J774 macrophages. The results show that PGE 2 is a potent inhibitor of purinergic signaling mediated by some, but not all, P2 receptors in macrophages.
Materials and Methods

Materials
PGE 2 was a generous gift from Ono Pharmaceutical (Osaka). ATP, UDP, benzoylbenzoyl-ATP (BzATP), 1-[6-[[17b-3-methoxyestra-1,3,5 (10)-trien-17-yl ]amino] hexyl]-1H-pyrrole-2,5-dione (U73122), Ivermectin, and fura-2-acetoxymethylester (AM) were from SigmaAldrich Japan (Tokyo). SYBR Premix EX Taq, random hexamer, and RNase inhibitor were from Takara Bio (Ohtsu). Moloney murine leukemia virus reverse transcriptase and RNase free DNase were from Invitrogen Japan (Tokyo). All other chemicals were reagent grade or the highest quality available.
Cell culture
Mouse J774.1 macrophages, obtained from RIKEN BRC CELL BANK (Tsukuba), were grown in RPMI1640 medium supplemented with 10% (v / v) heat-inactivated fetal bovine serum, 100 U /mL penicillin, and 100 μg/ mL streptomycin. Cells were maintained in 100-mm Petri dishes and incubated at 37°C in a humidified atmosphere of 95% air and 5% CO 2 .
RT-PCR
Total RNA was extracted from J774 cells by the acidguanidine thiocyanate / phenol / chloroform method (18) . First-strand cDNA primed by random hexamers was prepared from total RNA (1 μg) using Moloney murine leukemia virus reverse transcriptase in a final reaction volume of 20 μl as described previously (19) . The mouse brain cDNA was also prepared as described previously (19) and used as a positive control PCR template. The cDNA was diluted 5-fold with water and was used as a template for PCR analysis. The primers were designed using GENETX software to be selective for the purinoceptor subtypes on the basis of nucleotide sequence in the Genome Net Database Service (www.genome.ad.jp). The sense (S) and antisense (AS) primer sequences and the predicted length of PCR product (base pairs) are as follows:
PCR was carried out with 30 amplification cycles. The PCR products were separated by 1.5% agarose gel electrophoresis and visualized by ethidium bromide staining. The images were analyzed by using a photo image analyzer (LAS3000; FUJIFILM, Tokyo). In some experiments, mRNA levels were quantified using a realtime PCR system (Mx3000P; STRATAGENE, Japan) with SYBR ® Premix Ex Taq. Target mRNA expression in each sample was normalized to its GAPDH mRNA content.
[Ca
2+
] i measurement J774 cells were collected and washed once with Krebs-Ringer-HEPES (KRH) buffer (130 mM NaCl, 4.7 mM KCl, 4 mM NaHCO 3 , 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 11.5 mM glucose, 1.8 mM CaCl 2 , 10 mM HEPES, and 0.1% bovine serum albumin, adjusted to pH 7.4 with NaOH) by centrifugation at 200 × g for 3 min and resuspended with KRH buffer. The cell suspension was incubated at 37°C for 15 min with 1 μM fura-2-AM. The cells were then washed twice and finally resuspended at 1 -2 × 10 6 cells / mL in KRH buffer. The cells were kept at room temperature during the experiments. Aliquots of cell suspensions (1 mL) were centrifuged at 200 × g for 1 min in a microcentrifuge. The supernatant was discarded, and the cells were resuspended in 2 mL of fresh KRH buffer that had been pre-warmed to 37°C. The cell suspension was transferred into a 10 × 10-mm quartz cuvette placed in the thermostat-regulated sample chamber of a dual excitation beam spectrophotometer (F-2500; Hitachi, Tokyo). The cell suspension was stirred continuously with a stirring bar. The excitation wavelengths were 340 and 380 nm, and fura-2 fluorescence emission was measured at 510 nm. At the end of the measurements, Triton X-100 was added to the cell suspension to obtain maximal fluorescence and then excess EDTA was added to obtain minimal fluorescence. [Ca 2+ ] i was calculated from the ratio of the fluorescence at the two excitation wavelengths, with a K d value of 224 nM for the fura-2-Ca 2+ equilibrium (20) .
Macrophage inflammatory peptide-1α (MIP-1α) measurement J774 cells were seeded in a 48-well plate and grown to confluence. The cells were washed twice and incubated with serum-free RPMI 1640 medium at 37°C for 1 h in the presence or absence of various agents. After incubation, each culture medium was collected and centrifuged at 300 × g for 5 min at 4°C to remove the cells. The amounts of MIP-1α in the supernatant were assayed with ELISA kits, according to the manufacturer's instructions (R&D Systems, Minneapolis, MN, USA). The amount of protein of each well was measured using Protein Assay dye (Bio-Rad Laboratories, Tokyo).
Statistics
All values are expressed as the mean ± S.E.M. Data were analyzed by unpaired Student's t-tests for the two data comparison and one-way analysis of variance (ANOVA) with the Dunnett's two-tailed test for the multiple data comparison. P values of less than 0.05 were considered to be statistically significant.
Results
Purinergic receptors expressed in J774 cells
We first examined purinoceptor subtypes expressed in J774 cells. The primer sets used for amplification of P2X-and P2Y-receptor subtypes were able to amplify the target sequence specifically when mouse brain cDNA was used as template (Fig. 1A) . The conventional RT-PCR analysis detected the presence of four different purinoceptor mRNAs: the ionotropic P2X 4 and P2X 7 and G-protein-coupled P2Y 2 and P2Y 6 receptors, in J774 cells (Fig. 1A) . Relative amounts of the transcripts for these purinoceptor subtypes were further investigated by real-time PCR analysis. As shown in Fig. 1B , the P2Y 6 -receptor transcript was most abundant, being 8 -10 times higher than P2X 4 , P2X 7 , and P2Y 2 mRNA levels. ] i ) were investigated in fura-2-loaded cells. ATP at the concentration of 10 μM, which can stimulate P2X 4 and P2Y 2 receptors, induced Ca 2+ transient ( Fig. 2A) , whereas BzATP (500 μM), which can stimulate the P2X 7 -receptor channel, elicited a slowly developing large increase in [Ca 2+ ] i (Fig. 2C) . In addi- tion, UDP (10 μM), a selective P2Y 6 -receptor agonist, also triggered strong and sustained [Ca 2+ ] i elevation (Fig. 2B) . U73122 (1 μM), a phospholipase C (PLC) inhibitor, significantly reduced [Ca 2+ ] i elevation induced by 10 μM ATP and UDP, but not that by 500 μM BzATP (Fig. 3) ] i elevation by 10 μM ATP consists, at least in part, of the P2X 4 receptormediated component (Fig. 2: D and F) . ] i elevation induced by 10 μM ATP or 10 μM UDP (Fig. 4: A 
Effects of PGE
and B). On the other hand, [Ca
2+
] i elevation induced by 500 μM BzATP was almost unaffected by PGE 2 (Fig. 4C) ] i in J774 cells consists of two different components: the U73122-sensitive P2Y 2 receptor-mediated response and the ivermectin-sensitive P2X 4 receptormediated one. We therefore attempted to isolate the P2X 4 receptor-mediated component and examine the effect of PGE 2 on the Ca 2+ response through P2X 4 -receptor channels. In the presence of U73122 (1 μM), a condition where P2Y 2 receptor-mediated PLC activation was suppressed, ivermectin significantly augmented ] i elevation induced by 10 μM ATP (Fig. 5A) (Fig. 5B) . These results indicate that PGE 2 inhibits the Ca 2+ signal mediated by P2X 4 receptors.
Effects of PGE 2 on purinoceptor-mediated MIP-α production To determine the functional significance of inhibiting the purinoceptor-mediated Ca 2+ signal by PGE 2 , we measured release of the pro-inflammatory chemokine MIP-1α from J774 macrophages (Fig. 6 ). J774 cells produced and accumulated MIP-1α in the incubation medium. Although ATP (10 μM) had little effect on MIP-1α production, stimulation of cells with UDP (10 μM) and BzATP (500 μM) increased MIP-1α production significantly. PGE 2 (1 μM) decreased basal production of MIP-1α by itself and suppressed UDPstimulated MIP-1α production. In contrast, BzATPstimulated MIP-1α production was hardly affected by PGE 2 . These results were correlated with the inhibitory effects of PGE 2 on the Ca 2+ response induced by each purinoceptor agonists.
Discussion
The aim of present study is to explore the cross talk between the purinergic and prostanoid signalings in J774 macrophages. We first examined purinoceptor mRNA expression in J774 macrophages and identified four different subtypes: the ionotropic P2X 4 and P2X 7 receptors and the G-protein-coupled P2Y 2 and P2Y 6 receptors. These results are consistent with the distribution of purinoceptor subtypes in isolated alveolar and peritoneal macrophages (22, 23) and microglia in the nervous system (24) . In this study, pharmacological experiments with nucleotide agonists further revealed that all four purinoceptor subtypes, found at the gene transcription level, functionally mediate the nucleotide agonist-induced Ca 2+ response in J774 cells. Namely, the P2Y 2 agonist ATP at 10 μM and the P2Y 6 ] i . These results suggest that purinergic signals may trigger the macrophage activation.
PGE 2 is well known as the inflammatory mediator to generate pyrogenic fever (25) , hyperalgesia (26) , and inflammatory exudation (27) . However, several studies have shown that PGE 2 also exhibits inhibitory effects on not only early but also late processes involved in macrophage activation. Indeed, PGE 2 inhibits the production of cytokines such as TNF-α and IL-12 (28), as well as various chemokines (16, 17 (29 -32) . On the basis of the present results, PGE 2 may have minor role for modulation of the P2X 7 receptor-mediated inflammatory response. However, besides the P2X 7 receptor, various P2 receptors have been shown to mediate pathophysiological responses in immune cells. For example, in the microglia, macrophage-like cells in the nervous system, P2X 4 -receptor activation was shown to play a critical role for development of neuropathic pain (33) . In addition, P2Y 6 receptors have been shown to trigger phagocytosis (34) . As we showed in J774 cells that PGE 2 inhibited P2Y 6 receptor-mediated MIP-1α production, it may be important to evaluate the effects of PGE 2 on pathophysiological response mediated by P2Y 2 , P2Y 6 , and P2X 4 receptors in other immune cells.
PGE 2 exerts its biological effects through four Eprostanoid (EP) receptors, EP1 to EP4 (13) . In this study, we did not evaluate the EP-receptor subtype mediating the PGE 2 -induced inhibition of purinergic signaling. It has been shown that macrophage cells including J774 cells mainly expressed EP2-and EP4-receptor subtypes (35) , both of which are coupled to Gs, leading to an increase in cyclic AMP levels (13) . The cyclic AMP-dependent signal has been shown to inhibit macrophage function (14, 17) . It is therefore possible that PGE 2 activates the cyclic AMP signaling pathway via EP2 / EP4 receptors, resulting in inhibition of the purinoceptor-induced effects. We are currently investigating the mechanism underlying PGE 2 -induced inhibition of purinergic signals, including the identification of EP-receptor subtype in J774 cells.
In conclusion, we demonstrated in J774 macrophages that PGE 2 is a potent inhibitor of purinergic signals induced by G-protein-coupled P2Y 2 and P2Y 6 receptors as well as by ionotropic P2X 4 receptors. These effects of PGE 2 may be important for understanding the antiinflammatory effects of PGE 2 .
